Form D · Biotechnology
Genomic Expression, Inc.
New York, NY · CIK 0001611868
Offering snapshot reported Jun 25, 2014 · SEC filing
- Reported sold
- $200K Offering amount: $500K
- Investors reported
- 3 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Jun 15, 2014 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Jun 25, 2014 | Initial | $200,000 | No comparison | 3 | SEC filing |
Offering details
- Securities
- Debt, Other
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-219784
convertible promissory notes
Source: Form D, filed Jun 25, 2014. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Geoffrey Folkerth | Executive |
| Tanya Kanigan | Executive |
| Yota Palli | Director |
| Gitte Pedersen | Director, Executive |
| Morten Pedersen | Director, Executive |
| Jesper Zeuthen | Executive |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
375 Park Avenue Suite 2607
New York, NY, 10152
New York, NY, 10152